RE: Use the derampers to your advantage10 Feb 2021 08:05
To be fair Speranza, what he actually said was we have the best performing spike protein LFT in a lab setting, hence given the majority if not all other well publicised LFT’s target the N protein, this is arguably
not saying a great deal. Semantics maybe, but quite a big difference.
FWIW, I think we will have a great test and sell as many as we can make, but there is still a hell of a lot of unanswered questions around a number of subjects - I have no doubt all will be revealed in due course but it’s totally understandable that investors continue to have questions with regard to the science, the performance of the test, company strategy and likely commercial terms going forward.
All the best.